P.468 Cardiometabolic safety of lumateperone (ITI-007): post hoc analyses of short-term randomized trials and an open-label long-term study

Autor:	Suresh Durgam, R. Chen, K.E. Vanover, Christoph U. Correll, Robert E. Davis, S. Mates, A. Satlin
Rok vydání:	2020
Předmět:	Pharmacology medicine.medical_specialty Post hoc business.industry Term (time) law.invention Psychiatry and Mental health Long term learning Neurology Randomized controlled trial law Lumateperone Physical therapy Medicine Pharmacology (medical) Neurology (clinical) Open label business Biological Psychiatry
Zdroj:	European Neuropsychopharmacology. 40:S265-S266
ISSN:	0924-977X
DOI:	10.1016/j.euroneuro.2020.09.345
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1486347d68c6d9fe805f4ed5aa1a566e https://doi.org/10.1016/j.euroneuro.2020.09.345 Zobrazit plný text záznamu Full Text from ScienceDirect